No mutations found in candidate genes for dystocia

Human Reproduction

Volumn 14, Issue 10, 1999, Pages 2451-2454

  Algovik, Michael ^a   Lagercrantz, Jacob ^b   Westgren, Magnus ^a   Nordenskjold, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Vàstervik Hospital   (Sweden)

Author keywords

Dystocia; Endothelin 1 gene; Mutational screening; Prostaglandin F2 receptor gene; Testosterone 5 reductase type 1 gene

Indexed keywords

ENDOTHELIN 1; PROSTAGLANDIN F2 ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; STEROID 5ALPHA REDUCTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTOCIA; FEMALE; GENE MUTATION; HUMAN; LABOR COMPLICATION; RELATIVE;

EID: 0032825113     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.10.2451     Document Type: Article

References (18)

1. Abramovitch, M., Boie, Y., Nguyen, T. et al. (1994) Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem., 269, 2632-2636.
2. Arinami, T., Ishikawa, M., Inoue, A. et al. (1991) Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to Ip34, and the endothelin-3 gene (EDN3) to 20ql3.2-ql3.3. Am. J. Hum. Genet., 48, 990-996.
3. Berg-Lekås, M.-L., Högberg, U. and Winkvist, A. (1998) Familial occurrence of dystocia. Am. J. Obstet. Gynecol., 179, 117-121.
4. Betz, R., Lagercrantz, J., Kedra, D. et al. (1999) Genomic structure, 5′ flanking sequences and precise localization in Ip31.1 of the human prostaglandin F receptor gene. Biochem. Biopliys. Res. Com., 254, 413-416.
5. Chelmow, D., Kilpatrick, S J. and Laros, R.K. Jr. (1993) Maternal and neonatal outcomes after prolonged latent phase. Obstet. Gynecol, 81, 486-491.
6. Dizon-Tovvnson, D. and Ward, K. (1997) The genetics of labor. Clin. Obstet. Gynecol., 40, 479-484.
7. Inoue, A., Yanagisawa, N., Kimura, S. et al. (1989a) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA, 86, 2863-2867.
8. Inoue, A., Yanagisawa, M., Takuwa, Y. et al. (1989b) The human preproendothelin-l gene, complete nucleotide sequence and regulation of expression. J. Biol. Cliem., 264, 14954-14959.
9. Jenkins, E.P., Hsieh, C.-L., Milatovich, A. et al. (1991) Characterization and chromosomal mapping of a human steroid 5ct reductase gene and pseudogene and mapping of the mouse homologue. Genomics, 11, 1102-1112.
10. Jenkins, E.P., Anderson, S., Imperato, J. et al. (1992) Genetic and pharmacological evidence for more than one human steroid 5α reductase. J. Clin. Invest., 89, 293-300.
11. Johnstone, F. and Inglis, L. (1974) Familial trends in low birth weight. Br. Med.J., 3, 659-661.
12. Macara, L.M. and Murphy K.W. (1994) The contribution of dystocia to the cesarean section rate. Am. J. Obstet. Gynecol., 171, 71-77.
13. Mahendroo, M.S., Cala, K.M. and Russell, D.W. (1996) 5 alpha-reduced androgens play a key role in murine parturition. Mol. Endocrinol, 10, 380-392.
14. Saunders, N.S., Paterson, C.M. and Wadsworth, J. (1992) Nfconatal and maternal morbidity in relation to the length of the second stage of labour. Br. J. Obstet. Gynecol., 99, 381-385.
15. Sugimoto, Y., Yamasaki, A., Segi, E. et al. (1997) Failure of parturition in mice lacking the prostaglandin F receptor. Science, 277, 681-683.
16. Turcot, L., Marcoux, S. and Fraser, W.D. (1997) Multivariate analysis of risk factors for operative delivery in nulliparous women. Am. J. Obstet. Gynecol., 176, 395-402.
17. Vamer, M.W., Fraser, A.M., Hunter, C.Y. et al. (1996) The intergenerational predisposition to operative delivery. Obstet. Gynecol., 87, 905-911.
18. Ward, K., Hata, A., Jeuenemaitre, X. et al. (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet., 4, 59-61.